Trifluoromethylcinnamanilides - Effective dual inhibitors of Mycobacterium smegmatis and Plasmodium falciparum

. 2025 Jan ; 154 () : 107957. [epub] 20241119

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid39615279
Odkazy

PubMed 39615279
DOI 10.1016/j.bioorg.2024.107957
PII: S0045-2068(24)00862-9
Knihovny.cz E-zdroje

A series of eighteen new 2-trifluoromethylcinnamanilides (1a-r) were synthesized by microwave synthesis and investigated for their antimycobacterial and antimalarial activities, along with the complementary (2E)-3-[3-(trifluoromethyl)phenyl]-N-arylprop-2-enanilides (2a-r) and (2E)-3-[4-(trifluoromethyl)phenyl]-N-arylprop-2-enanilides (3a-r) prepared earlier. All the compounds were evaluated in vitro against Mycobacterium smegmatis ATCC 700084 and a chloroquine-sensitive strain of Plasmodium falciparum 3D7/MRA-102. The most active compounds against M. smegmatis (MIC values in the range of 1.17-11.1 µM, more effective than rifampicin) were anilides substituted by 3,5-CF3 (1q, 2q, 3q), 4-OCF3 (1k), and 4-CF3 (1j, 2j). The most effective agents against P. falciparum (IC50 values in the range of 0.32-4.5 µM, comparable to chloroquine) were anilides substituted by 3,5-CF3 (1q, 2q, 3q), 2-Br-4-OCF3 (1r), 4-CF3 (1j, 3j), 4-F (2d), 4-Cl (2g), 2-Cl (1e, 2e). A preliminary in vitro cytotoxicity screening was assessed using human leukemic cell lines and human dermal fibroblasts, revealing the toxic effect of 3,5-CF3 substituted anilides. On the other hand, the other investigated agents showed insignificant cytotoxic effects. Stability assays using rat liver microsomes demonstrated that compounds 1r (R = 2-Br-4-OCF3) and 1q (R = 3,5-CF3) are neither metabolized nor affect cytochrome P450 metabolizing capacity in vitro. Furthermore, complex in silico studies were performed - a combined approach (docking/MD simulations/QTAIM calculations) helped to define the molecular interactions that were applied during the binding of active agents and the subsequent inhibition of their molecular targets - InhA (activity against M. smegmatis) and arginase (activity against P. falciparum). In conclusion, promising active agents with dual antimycobacterial and antimalarial effects were identified.

Department of Biochemistry Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czech Republic

Department of Chemical Biology Faculty of Science Palacky University Olomouc Slechtitelu 27 779 00 Olomouc Czech Republic; Institute of Chemistry University of Silesia Szkolna 9 40 007 Katowice Poland

Department of Chemical Drugs Faculty of Pharmacy Masaryk University Palackeho 1946 1 612 00 Brno Czech Republic

Department of Experimental Biology Faculty of Science Palacky University Olomouc Slechtitelu 27 779 00 Olomouc Czech Republic

Department of Infectious Diseases and Microbiology Faculty of Veterinary Medicine University of Veterinary Sciences Brno Palackeho tr 1946 1 612 42 Brno Czech Republic

Department of Molecular Pharmacy Faculty of Pharmacy Masaryk University Palackeho 1946 1 612 00 Brno Czech Republic

Department of Pharmacology Faculty of Medicine Masaryk University Kamenice 5 625 00 Brno Czech Republic

Faculty of Chemistry Biochemistry and Pharmacy National University of San Luis IMIBIO CONICET Ejército de los Andes 950 5700 San Luis Argentina

Global Change Research Institute CAS Belidla 986 4a 603 00 Brno Czech Republic

Laboratory of Medicinal Chemistry CIRM Center for Interdisciplinary Research on Medicines University of Liege Avenue Hippocrate 15 4000 Liege Belgium

Laboratory of Pharmacognosy CIRM Center for Interdisciplinary Research on Medicines University of Liege Avenue Hippocrate 15 4000 Liege Belgium

Renslo's Lab Department of Pharmaceutical Chemistry University California San Francisco 600 16 Street 94143 San Francisco CA USA

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...